Disease modelling and drug development with iPSC-derived cells: a brave new world?
DOI:
https://doi.org/10.25753/BirthGrowthMJ.v29.i1.19728Downloads
Download data is not yet available.
References
NIH Stem Cell Information Home Page. In Stem Cell Information [World Wide Web site]. Bethesda, MD: National Institutes of Health, U.S. Department of Health and Human Services, 2016 [cited March 23, 2020] Available at https://stemcells.nih.gov/info/basics/6.htm.
Elitt MS, Barbar L, Tesar PJ. Drug screening for human genetic diseases using iPSC models. Human Molecular Genetics. 2018; 27:R89–R98.
Karagiannis P, Takahashi K, Saito M, Yoshida Y, Okita K, Watanabe A, et al. Induced pluripotent stem cells and their use in human models of disease and development. Physiol Rev. 2019; 99:79-114.
Ilic D, Devito L, Miere C, Codognotto S. Human embryonic and induced pluripotent stem cells in clinical trials. British Medical Bulletin, 2015, 116:19–27.
Yamanaka S. Induced Pluripotent Stem Cells: Past, Present, and Future. Cell Stem Cell. 2012; 10:678-84.
Ustyantseva EI, Medvedev SP, Vetchinova AS, Illarioshkin SN, Leonov SV, Zakian SM. Generation of an induced pluripotent stem cell line, ICGi014-A, by reprogramming peripheral blood mononuclear cells from a patient with homozygous D90A mutation in SOD1 causing Amyotrophic lateral sclerosis. Stem Cell Res. 2020; 42:101675.
Rodríguez-Traver E, Díaz-Guerra E, Rodríguez C, Arenas F, Orera M, Kulisevsky J, A collection of three integration-free iPSCs derived from old male and female. Stem Cell Research. 2020; 42: 101663.
Elitt MS, Barbar L, Tesar PJ. Drug screening for human genetic diseases using iPSC models. Human Molecular Genetics. 2018; 27:R89–R98.
Karagiannis P, Takahashi K, Saito M, Yoshida Y, Okita K, Watanabe A, et al. Induced pluripotent stem cells and their use in human models of disease and development. Physiol Rev. 2019; 99:79-114.
Ilic D, Devito L, Miere C, Codognotto S. Human embryonic and induced pluripotent stem cells in clinical trials. British Medical Bulletin, 2015, 116:19–27.
Yamanaka S. Induced Pluripotent Stem Cells: Past, Present, and Future. Cell Stem Cell. 2012; 10:678-84.
Ustyantseva EI, Medvedev SP, Vetchinova AS, Illarioshkin SN, Leonov SV, Zakian SM. Generation of an induced pluripotent stem cell line, ICGi014-A, by reprogramming peripheral blood mononuclear cells from a patient with homozygous D90A mutation in SOD1 causing Amyotrophic lateral sclerosis. Stem Cell Res. 2020; 42:101675.
Rodríguez-Traver E, Díaz-Guerra E, Rodríguez C, Arenas F, Orera M, Kulisevsky J, A collection of three integration-free iPSCs derived from old male and female. Stem Cell Research. 2020; 42: 101663.
Downloads
Published
2020-03-24
How to Cite
1.
Oliva-Teles N. Disease modelling and drug development with iPSC-derived cells: a brave new world?. REVNEC [Internet]. 2020Mar.24 [cited 2024Apr.19];29(1):7-8. Available from: https://revistas.rcaap.pt/nascercrescer/article/view/19728
Issue
Section
Editorial
License
Copyright and access
This journal offers immediate free access to its content, following the principle that providing free scientific knowledge to the public provides greater global democratization of knowledge.
The works are licensed under a Creative Commons Attribution Non-commercial 4.0 International license.
Nascer e Crescer – Birth and Growth Medical Journal do not charge any submission or processing fee to the articles submitted.
